Warburg Pincus

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Mariner Finance is a Baltimore-based consumer finance company that focuses on providing tailored financial solutions to meet the specific needs of its customers. The company offers a range of products, including medium-term installment loans, personal loans, car loans, home loans, and credit insurance, primarily targeting near-prime borrowers. Mariner Finance distinguishes itself through its commitment to exceptional customer service, which is viewed as essential for building lasting relationships in the communities it serves. By prioritizing quality service and maintaining a local approach, Mariner Finance aims to not only meet but exceed the expectations of its clients, reinforcing its reputation as the preferred consumer finance company in the area.

Competitive Power Ventures Holdings, LLC (CPV) is a prominent electric power generation development and asset management company based in Silver Spring, Maryland, with additional offices in Massachusetts, California, and Ontario, Canada. The company focuses on creating substantial new clean energy supplies in strategic markets, leveraging its operational expertise and commitment to community values. CPV's experienced development team emphasizes a clean energy strategy that incorporates combined-cycle natural gas and wind-powered generation to address the increasing demand for electricity in high-load areas across North America. Currently, CPV has nearly 5,000 megawatts (MWs) of natural gas projects at various development stages, with plans to initiate construction on approximately 1,400 MWs within the next year. The company anticipates an additional 1,200 MWs of projects annually. In addition, CPV's Asset Management division has been responsible for operating over 8,000 MWs of generation capacity since 2001 and currently manages 6,100 MWs across the continent.

GlobalSpec, Inc. is a specialized information services and e-publishing company that caters to the engineering and manufacturing sectors. Founded in 1996 and based in East Greenbush, New York, the company provides domain-specific search engines, web-based content, and industry newsletters for users seeking information on various products and services. Its offerings encompass a wide range of product categories, including building and construction materials, electrical and electronic components, industrial equipment, and laboratory instruments. GlobalSpec also delivers filtered sales leads, product promotion, and advertising services for businesses aiming to reach their target audiences effectively. Additionally, the company offers customized marketing programs to enhance visibility and campaign performance across multiple sectors, including construction, automotive, aerospace, and life sciences. GlobalSpec operates sales offices in New York and Maryland, with media representatives in various international locations, including China, Germany, and Taiwan.